{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:42:47Z","timestamp":1792489367983,"version":"4.5.0"},"reference-count":28,"publisher":"BMJ","issue":"3","funder":[{"name":"CoSRH","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Sex Reprod Health"],"accepted":{"date-parts":[[2026,5,4]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Psychological side effects are a frequent reason for discontinuation of hormonal contraception (HC), yet women with pre-existing mental health (MH) conditions are often excluded from studies despite their prevalence and needs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To examine the effects of HC used for pregnancy prevention on anxiety and mood (affective) symptoms in women with established MH disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>MEDLINE, Embase and Cochrane CENTRAL were systematically searched for English-language studies published between 2015 and 2025. Randomised controlled trials, cohort and cross-sectional studies evaluating any HC type in women with clinically diagnosed or self-reported anxiety or mood (affective) disorders were included. Studies assessing HC for therapeutic indications were excluded. Screening and data extraction followed Cochrane Rapid Review guidance. Due to heterogeneity in study designs and outcomes, findings were narratively synthesised by contraceptive type and population (adult, adolescent, postpartum).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ten studies met inclusion criteria. HC use did not consistently worsen anxiety or mood symptoms in women with pre-existing MH disorders. Combined oral contraceptives (COCs) showed largely neutral effects, with some studies reporting increased mood symptoms, while progestogen-only methods and levonorgestrel intrauterine devices were associated with stable or improved symptoms. Negative associations were less pronounced in women with existing disorders than in those without prior MH conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HC appears generally safe for women with established anxiety or mood (affective) disorders. Symptoms were largely stable or modestly improved, with adverse effects reported more often with COCs, particularly among adolescents and first-time users. Individualised contraceptive counselling is recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjsrh-2026-203256","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T17:20:20Z","timestamp":1780939220000},"page":"200-208","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of hormonal contraception in individuals with anxiety and mood (affective) disorders: a rapid review"],"prefix":"10.1136","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0924-2343","authenticated-orcid":false,"given":"Alexandra-Andreea","family":"Ciritel","sequence":"first","affiliation":[{"name":"College of Sexual and Reproductive Health, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Boxer","sequence":"additional","affiliation":[{"name":"College of Sexual and Reproductive Health, London, UK"},{"name":"Department of Women & Children\u2019s Health, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kelly","sequence":"additional","affiliation":[{"name":"College of Sexual and Reproductive Health, London, UK"},{"name":"Brixton Hill Group Practice, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaqueline","family":"Quinn","sequence":"additional","affiliation":[{"name":"College of Sexual and Reproductive Health, London, UK"},{"name":"Centre for Reproductive Health, Institute for Regeneration and Repair, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2444-3773","authenticated-orcid":false,"given":"Kate","family":"Foster","sequence":"additional","affiliation":[{"name":"College of Sexual and Reproductive Health, London, UK"},{"name":"University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Strauss","sequence":"additional","affiliation":[{"name":"College of Sexual and Reproductive Health, London, UK"},{"name":"Locala Health & Wellbeing, Dewsbury, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"2026102002201890000_52.3.200.1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwt186"},{"key":"2026102002201890000_52.3.200.2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/13625187.2022.2030702","article-title":"Discontinuation of hormonal contraception due to changes in mood and decreases in sexual desire: the role of adverse childhood experiences","volume":"27","author":"Novick","year":"2022","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"2026102002201890000_52.3.200.3","doi-asserted-by":"crossref","first-page":"116081","DOI":"10.1016\/j.socscimed.2023.116081","article-title":"Interrogating the pill: Rising distrust and the reshaping of health risk perceptions in the social media age","volume":"331","author":"Schneider-Kamp","year":"2023","journal-title":"Soc Sci Med"},{"key":"2026102002201890000_52.3.200.4","doi-asserted-by":"publisher","DOI":"10.1037\/bul0000102"},{"key":"2026102002201890000_52.3.200.5","unstructured":"United Nations . World fertility and family planning 2020 highlights. 2010. Available: https:\/\/www.un.org\/en\/development\/desa\/population\/publications\/pdf\/family\/World_Fertility_and_Family_Planning_2020_Highlights.pdf"},{"key":"2026102002201890000_52.3.200.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2023.101111"},{"key":"2026102002201890000_52.3.200.7","doi-asserted-by":"publisher","DOI":"10.1080\/13625187.2016.1217327"},{"key":"2026102002201890000_52.3.200.8","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2021.64","article-title":"Hormonal contraceptive use and depressive symptoms: systematic review and network meta-analysis of randomised trials","volume":"7","author":"de Wit","year":"2021","journal-title":"BJPsych Open"},{"key":"2026102002201890000_52.3.200.9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/13625187.2019.1569610","article-title":"Postpartum hormonal contraception use and incidence of postpartum depression: a systematic review","volume":"24","author":"Ti","year":"2019","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"2026102002201890000_52.3.200.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12884-024-06587-9","article-title":"Assessing the impact of contraceptive use on mental health among women of reproductive age - a systematic review","volume":"24","author":"Jahanfar","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"2026102002201890000_52.3.200.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2016.06.012"},{"key":"2026102002201890000_52.3.200.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2020.10.007"},{"key":"2026102002201890000_52.3.200.13","doi-asserted-by":"crossref","unstructured":"Page MJ , McKenzie JE , Bossuyt PM , et al . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;n71. doi:10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"2026102002201890000_52.3.200.14","unstructured":"Substance Abuse and Mental Health Services Administration (US) . 3.2.3. Disorder reclassification. In: Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health. CBHSQ Methodology Report. 2016. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519704\/#ch3.s2"},{"key":"2026102002201890000_52.3.200.15","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"2026102002201890000_52.3.200.16","unstructured":"Critical Appraisal Skills Programme UK . Critical appraisal checklists. 2026. Available: https:\/\/casp-uk.net\/casp-tools-checklists\/"},{"key":"2026102002201890000_52.3.200.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsrh-2024-202424"},{"key":"2026102002201890000_52.3.200.18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/13625187.2017.1422239","article-title":"Ongoing or previous mental disorders predispose to adverse mood reporting during combined oral contraceptive use","volume":"23","author":"Bengtsdotter","year":"2018","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"2026102002201890000_52.3.200.19","doi-asserted-by":"crossref","unstructured":"Morssinkhof MWL , Lamers F , Hoogendoorn AW , et al . Oral contraceptives, depressive and insomnia symptoms in adult women with and without depression. Psychoneuroendocrinology 2021;133. doi:10.1016\/j.psyneuen.2021.105390","DOI":"10.1016\/j.psyneuen.2021.105390"},{"key":"2026102002201890000_52.3.200.20","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.13476"},{"key":"2026102002201890000_52.3.200.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049553","article-title":"Population heterogeneity in associations between hormonal contraception and antidepressant use in Sweden: a prospective cohort study applying intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA)","volume":"11","author":"Zettermark","year":"2021","journal-title":"BMJ Open"},{"key":"2026102002201890000_52.3.200.22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejogrb.2023.06.026","article-title":"Effects of Drospirenone only pill contraception on postpartum mood disorders: A prospective, comparative pilot study","volume":"288","author":"Caruso","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026102002201890000_52.3.200.23","doi-asserted-by":"crossref","DOI":"10.61622\/rbgo\/2025rbgo9","article-title":"Contraception in adolescents with mental disorders: adherence and satisfaction in the use of depot medroxyprogesterone acetate","volume":"47","author":"Cezimbra","year":"2025","journal-title":"Rev Bras Ginecol Obstet"},{"key":"2026102002201890000_52.3.200.24","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s40264-018-0683-x","article-title":"Cohort Study of Psychiatric Adverse Events Following Exposure to Levonorgestrel-Containing Intrauterine Devices in UK General Practice","volume":"41","author":"Slattery","year":"2018","journal-title":"Drug Saf"},{"key":"2026102002201890000_52.3.200.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmjsrh-2020-200658","article-title":"Towards individualised contraceptive counselling: clinical and reproductive factors associated with self-reported hormonal contraceptive-induced adverse mood symptoms","volume":"47","author":"Lundin","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"key":"2026102002201890000_52.3.200.26","doi-asserted-by":"crossref","DOI":"10.1186\/s40834-022-00204-w","article-title":"Psychological side effects of hormonal contraception: a disconnect between patients and providers","volume":"8","author":"Martell","year":"2023","journal-title":"Contracept Reprod Med"},{"key":"2026102002201890000_52.3.200.27","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2024.1462891","article-title":"Current oral contraceptive use affects explicit and implicit measures of depression in women","volume":"15","author":"Hampson","year":"2024","journal-title":"Front Psychol"},{"key":"2026102002201890000_52.3.200.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144263","article-title":"Factors Affecting the Timing of Signal Detection of Adverse Drug Reactions","volume":"10","author":"Hashiguchi","year":"2015","journal-title":"PLoS One"}],"container-title":["BMJ Sexual &amp; Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjsrh-2026-203256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:21:18Z","timestamp":1792488078000},"score":1,"resource":{"primary":{"URL":"https:\/\/jfprhc.bmj.com\/lookup\/doi\/10.1136\/bmjsrh-2026-203256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7,10]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/bmjsrh-2026-203256"],"URL":"https:\/\/doi.org\/10.1136\/bmjsrh-2026-203256","relation":{},"ISSN":["2515-1991","2515-2009"],"issn-type":[{"value":"2515-1991","type":"print"},{"value":"2515-2009","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]}}}